Matthew Phillip Sinnreich, President and Acting CEO at Organicell Regenerative Medicine, Inc. (OCEL), sold 20,000 shares at $0.04 ($800) on 2022-10-13, disclosed to the SEC on 2022-10-17.
Open-market sale of $800 OCEL by President and Acting CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.